Talmo Paul 4
4 · TELA Bio, Inc. · Filed Feb 24, 2026
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
Talmo Paul
Chief Technology Officer
Transactions
- Award
Common Stock
[F1]2026-02-20+57,000→ 180,882 total - Tax Payment
Common Stock
[F2]2026-02-21$0.72/sh−3,385$2,428→ 177,497 total - Tax Payment
Common Stock
[F2]2026-02-23$0.77/sh−4,061$3,111→ 173,436 total - Award
Stock Option (Right to Buy)
[F3]2026-02-20+85,000→ 85,000 totalExercise: $0.72Exp: 2036-02-20→ Common Stock (85,000 underlying)
Footnotes (3)
- [F1]These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates.
- [F2]Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
- [F3]The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.
Signature
/s/ Megan Smeykal, Attorney-in-Fact|2026-02-24